# reload+after+2024-01-22 13:44:13.031475
address1§2265 Upper Middle Road East
address2§Suite 602
city§Oakville
state§ON
zip§L6H 0G5
country§Canada
phone§289 910 0850
website§https://www.cardiolrx.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
companyOfficers§[{'maxAge': 1, 'name': 'Mr. David G. Elsley MBA', 'title': 'President, CEO & Director', 'fiscalYear': 2022, 'totalPay': 488786, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA', 'title': 'CFO, Corporate Secretary & Director', 'fiscalYear': 2022, 'totalPay': 185444, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bernard  Lim B.Sc.', 'title': 'Chief Operating Officer', 'fiscalYear': 2022, 'totalPay': 310958, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Andrew Warwick Hamer M.D.', 'age': 61, 'title': 'Chief Medical Officer & Head of Research & Development', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 370058, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Trevor  Burns', 'title': 'Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§1
boardRisk§4
compensationRisk§10
shareHolderRightsRisk§2
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.923
currency§USD
dateShortInterest§1702598400
forwardEps§-0.31
exchange§NCM
quoteType§EQUITY
shortName§Cardiol Therapeutics Inc.
longName§Cardiol Therapeutics Inc.
firstTradeDateEpochUtc§1547562600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ee9d962b-eed4-3063-8df9-c815990fe5d8
gmtOffSetMilliseconds§-18000000
targetHighPrice§5.99
targetLowPrice§5.99
targetMeanPrice§5.99
targetMedianPrice§5.99
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§5.085
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
